Motility News

The incidence and prevalence of achalasia in central Chicago diagnosed using high-resolution manometry are two to three times greater than the previous estimates, according to recent findings published in Clinical Gastroenterology and Hepatology.

A recent literature review suggested that probiotics could help manage HIV patients’ CD4 counts and medication-related diarrhea, although more studies are required to confirm these benefits and determine best practices.

The FDA has approved 450 mg once daily Relistor tablets for the treatment of opioid-induced constipation in adults with chronic noncancer pain, the manufacturer announced.

The CDC recommends clinicians not use any liquid docusate product as a stool softener for patients until further notice since the origin of a multistate outbreak of Burkholderia cepacia infections at five health care facilities reported in June remains undetermined.

Total epithelial thickness was a robust histologic marker for GERD, according to a post hoc analysis of data from the Diamond study.

Takeda Pharmaceuticals announced the FDA has approved Dexilant for patients aged between 12 and 17 years with GERD. The medication has been approved for adults since 2009.

Researchers found that use of particular laxatives was 'wasteful,' according to a research letter published in JAMA Internal Medicine.

GERD is common among patients with proton pump inhibitor-responsive esophageal eosinophilia, suggesting that the two conditions may share similar pathogenic mechanisms, according to an Italian study published in Alimentary Pharmacology and Therapeutics.

An accurate diagnosis via laboratory testing is critical for effectively treating persistent diarrhea lasting more than 2 weeks, as the often poorly recognized syndrome can be caused by different pathogens than acute diarrhea, according to a clinical review recently published in JAMA.

Adults with diabetic gastroparesis experienced accelerated gastric emptying and reduced vomiting with 10 µg of subcutaneous relamorelin administered twice daily, according to phase 2 trial data.